Join to access to all OVN content. Join for Free

Results for 'MSL transition'

Tom Caravela

“Extreme Interviewing” – MSL Interview Tips and Insights from Medical Affairs Leaders

Jul 9^th • 1 min read

Tom Caravela

Job Search Checklist for Aspiring Medical Science Liaisons

May 17^th • 2 mins read

Tom Caravela

MSL Retention – What Matters Most

Mar 15^th • 2 mins read

Tom Caravela

MSL Hiring and Recruitment: 5 Ways to Support Diversity and Inclusion

May 19^th • 2 mins read

Tom Caravela

Resume Writing and Editing Tips for Pharma Professionals

Aug 8^th • 1 min read

Bridget Rasmusson

6 Tips to Ace Your Next MSL Interview!

Sep 28^th • 1 min read

Bridget Rasmusson

Presentation Nails and Fails: 7 Tips to Ace Your Next MSL Presentation

Oct 12^th • 1 min read

Tom Caravela

Combatting the “Summer Slow Down" – MSL Job Search Tips for Slower Months

Jun 23^rd • 2 mins read

Tom Caravela

MSL Evolution: New Trends and Titles That May Emerge

Apr 5^th • 1 min read

Tom Caravela

MSL People Skills: Top 10 Tips for Better Engagement

Apr 20^th • 8 mins read

Tom Caravela

Promotability: How to Land Your Next Promotion

May 5^th • 10 mins read

Bridget Rasmusson

Positioning Yourself to Become an MSL in 2022

Dec 21^st • 10 mins read

Tom Caravela

What to do When a Job Offer is Rescinded

Jul 20^th • 5 mins read

iNIZIO

Virtual Oncology MSL Team Increases KOL Engagement by 120%

Sep 3^rd • 1 min read

Sean X Zhang, MSc , Dean Fergusson, PhD , Jonathan Kimmelman, PhD

Proportion of Patients in Phase I Oncology Trials Receiving Treatments That Are Ultimately Approved

Apr 1^st • 14 mins read

Envision Pharma Group

Medical affairs: The power behind redefining commercialization

Aug 2^nd • 3 mins read

Neil Carleton and Priscilla F. McAuliffe

Are the chronological age cutoffs used in clinical oncology guidelines biologically meaningful?

Dec 1^st • 4 mins read

Related Topics

See More Topics

Voices of Oncology

Envision Pharma Group